oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
HEStaff exchange2026–2030Türkiye
OMNIA · Orchestrating Multi-Omic Nanomedicine Insights with AI and Spatial Biology–Driven Innovation and Training for Hard-to-Treat Cancers
23 partners · 15 countries
HEIndividual fellowship2026–2028Denmark
FUNFACTs · Fundamental Understanding of shelteriN Function and Architecture on Chromatinized Telomeres
HEIndividual fellowship2026–2028Switzerland
ProtEAMPs · Protease activated encrypted antimicrobial peptides
2 partners · 2 countries
HEIndividual fellowship2026–2028Czechia
LUCENT · Light-triggered Ultra-precise Carbon-enhanced phycocyanin Engineered Needles for Therapy
2 partners · 2 countries
HEIndividual fellowship2026–2028United Kingdom
RBPandALT · Investigating the role of RNA-binding proteins in telomere replication stress and alternative lengthening of telomeres
HEIndividual fellowship2026–2028United Kingdom
SPEAK-PPI · Structure-guided Peptide Engineering for Aurora B Kinase Protein-Protein Interaction
HEIndividual fellowship2026–2028United Kingdom
PRIME · A Proteoform-Resolved Lateral Flow Immunoassay with Antibody Mimics and Engineered Release for Precise Prostate Cancer Diagnosis
HEIndividual fellowship2026–2028Spain
semiQ2 · Semiquantification based on ionization efficiency for human exposure leveraging ion mobility separation
HEIndividual fellowship2026–2028Italy
LUCI · Label-free sUper-resolution imaging via bound-states in the ContInumm
HEIndividual fellowship2026–2028Spain
NuMAP-TNBC · Nuclear Metabolism Mapping to Predict Therapeutic Response in Triple Negative Breast Cancer
HEIndividual fellowship2026–2028Spain
Triple-R · Identification of long non-coding RNA-based biomarkers of immunotherapy response in Triple-Negative Breast Cancer via liquid biopsy profiling
HEIndividual fellowship2026–2029Germany
MPN2AML · Identification of novel genetic regulators governing leukaemic transformation from myeloid proliferative neoplasms
2 partners · 2 countries
HEIndividual fellowship2026–2028Germany
FerroDRP1 · Deciphering the role of DRP1 in the spatio-temporal regulation of lipid peroxidation during ferroptosis
HEIndividual fellowship2026–2028Norway
ADHESYS · A Breakthrough Mucoadhesive 3D-Printed Delivery System to Treat Oral Mucositis in Cancer Patients
2 partners · 2 countries
HEIndividual fellowship2026–2028Denmark
WILSON · Wilson transporter ATP7B: Interactions, Lipids, Structure and RegulatiON
HEIndividual fellowship2026–2028Germany
EpiGen-LC · Epigenetic and Genetic interplay in Liver Cancer
HEIndividual fellowship2026–2028United Kingdom
RadBO · Cracking the Radiochemical Black Box with Bayesian Optimisation
HEIndividual fellowship2026–2028United Kingdom
MIRACLE · Mechanically Interlocked Radiotracers Chelators for Efficient Cancer Therapy
2 partners · 2 countries
HEIndividual fellowship2026–2028Spain
PRODIGIO · PROton therapy DIfferentiable Gradient-based Inverse Optimization
3 partners · 2 countries
HEIndividual fellowship2026–2029Spain
AlphaLymph · Integrated Assessment of Indoor Radon and Hazardous Air Pollutants in Non-Hodgkin Lymphoma – a Case-Control Study in a Radon-Prone Area
3 partners · 2 countries
HEIndividual fellowship2026–2028France
3DCellID · How 3D genome organization allows cells to learn and remember their identity
HEIndividual fellowship2026–2028Ireland
EPiTOME-M · Epigenetic Profiling and Telomere-Orchestrated Mechanisms in HPV+ Oropharyngeal Cancer
2 partners · 2 countries
HEIndividual fellowship2026–2028Norway
SENS-PFAS · A Multi-Modal Spectroelectrochemical Sensor Platform for the Real-Time Detection of Per- and Polyfluoroalkyl Substances (PFAS) using Advanced Data Fusion
HEIndividual fellowship2026–2028Spain
siRNA-MOPs · Molecular Spherical Nucleic Acids for Glioblastoma Treatment
2 partners · 2 countries